1. Huang, Zhen, Xu, Enjie, Ma, Xiaolong, Hu, Jianping, Zhang, Chunlin. 2024. Low NT5DC2 expression predicts favorable prognosis and suppresses soft tissue sarcoma progression via ECM-receptor interaction pathway. In Translational oncology, 44, 101937. doi:10.1016/j.tranon.2024.101937. https://pubmed.ncbi.nlm.nih.gov/38547613/
2. Schulze, Arik Bernard, Kuntze, Anna, Schmidt, Lars Henning, Bleckmann, Annalen, Evers, Georg. 2022. High Expression of NT5DC2 Is a Negative Prognostic Marker in Pulmonary Adenocarcinoma. In Cancers, 14, . doi:10.3390/cancers14061395. https://pubmed.ncbi.nlm.nih.gov/35326547/
3. Sha, Rula, Zhang, Jiaming, Meng, Fanjie, Zhaori, Getu. . Gastric cancer metastasis-related NT5DC2 indicates unfavorable prognosis of patients. In Medicine, 102, e35030. doi:10.1097/MD.0000000000035030. https://pubmed.ncbi.nlm.nih.gov/37800836/
4. Chen, Jiemin, Cao, Jianzhong, Wang, Penghui, He, Xiaodong. 2020. NT5DC2 is a novel prognostic marker in human hepatocellular carcinoma. In Oncology letters, 20, 70. doi:10.3892/ol.2020.11931. https://pubmed.ncbi.nlm.nih.gov/32863903/
5. Nakashima, Akira, Yamaguchi, Hisateru, Kondo, Mii, Nagatsu, Toshiharu, Ota, Akira. 2020. NT5DC2 affects the phosphorylation of tyrosine hydroxylase regulating its catalytic activity. In Journal of neural transmission (Vienna, Austria : 1996), 127, 1631-1640. doi:10.1007/s00702-020-02236-5. https://pubmed.ncbi.nlm.nih.gov/32778969/
6. Guo, Saisai, Ran, Haowen, Xiao, Dake, Li, Ailing, Man, Jianghong. 2019. NT5DC2 promotes tumorigenicity of glioma stem-like cells by upregulating fyn. In Cancer letters, 454, 98-107. doi:10.1016/j.canlet.2019.04.003. https://pubmed.ncbi.nlm.nih.gov/30978441/
7. Li, Kang-Shuai, Zhu, Xiao-Dong, Liu, Hong-Da, Tang, Zhao-You, Sun, Hui-Chuan. 2020. NT5DC2 promotes tumor cell proliferation by stabilizing EGFR in hepatocellular carcinoma. In Cell death & disease, 11, 335. doi:10.1038/s41419-020-2549-2. https://pubmed.ncbi.nlm.nih.gov/32382041/
8. Jin, Xiang, Liu, Xingang, Zhang, Zhen, Xu, Lijun. 2020. NT5DC2 suppression restrains progression towards metastasis of non-small-cell lung cancer through regulation p53 signaling. In Biochemical and biophysical research communications, 533, 354-361. doi:10.1016/j.bbrc.2020.06.139. https://pubmed.ncbi.nlm.nih.gov/32962856/
智鼠故事 
